Blog
RSS FeedPosted by Michael Wonder on 12 Feb 2019
Yescarta rejected among other SMC decisions
12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...
Posted by Michael Wonder on 11 Feb 2019
SMC - February 2019 decisions
11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today ...
Posted by Michael Wonder on 14 Jan 2019
Life-extending drug Perjeta approved for secondary breast cancer
14 January 2019 - A drug used to treat advanced breast cancer has been approved for use on the NHS ...
Posted by Michael Wonder on 14 Jan 2019
SMC - January 2019 decisions
14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...
Posted by Michael Wonder on 10 Dec 2018
Perjeta given green light in Scotland as early stage breast cancer treatment
10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...
Posted by Michael Wonder on 10 Dec 2018
SMC - December 2018 decisions
10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for ...
Posted by Michael Wonder on 12 Nov 2018
SMC - November 2018 decisions
12 November 2018 - A medicine used to treat a rare cancer which occurs predominantly in very young children has ...
Posted by Michael Wonder on 08 Oct 2018
SMC - October 2018 decisions
8 October 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...
Posted by Michael Wonder on 10 Sep 2018
SMC - September 2018 decisions
10 September 2018 - The Scottish Medicines Consortium, has today published advice accepting four new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 13 Aug 2018
SMC - August 2018 decisions
13 August 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...
Posted by Michael Wonder on 09 Jul 2018
SMC rejects ocrelizumab (Ocrevus) for relapsing remitting MS in Scotland
9 July 2018 - The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as ...
Posted by Michael Wonder on 09 Jul 2018
SMC - July 2018 decisions
9 July 2018 - The SMC, which advises NHSScotland on newly licensed medicines, has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...
Posted by Michael Wonder on 12 Jun 2018
SMC approves funding for six new therapies on the NHS
12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...
Posted by Michael Wonder on 11 Jun 2018
SMC - June 2018 decisions
11 June 2018 - The SMC, has today published advice accepting six new medicines for use by NHSScotland. ...